chimerism immune reconstitution and outcome after allogeneic myeloablative and reduced intensity unrelated and haploidentical pbsc transplantation using post transplant cyclophosphamide

S168 Abstracts / Biol Blood Marrow Transplant 21 (2015) S147eS170 Table Cells/mm3 All Patients TFM/Cy FluBu2/ATG CB P value CD3- D30 D100 year CD4- D30 D100 year CD19- D30 D100 year T-reg D30 D100 year NK-cells- D30 D100 year IgA- D30 D100 year IgG- D30 D100 year IgM- D30 D100 year 284 518 669 100 175 251 41.5 184.5 14 18.5 22 136 150 143 59 60.5 58 593 612 760 29 30.2 52.2 376 598.5 744.5 111 189 293 24 204 16 20 21.5 29 110 132.5 46 26 51 534 494 784 23.1 17.0 42.2 277 1159 690 129.5 276 269 73.5 96 10.5 29.1 38 205 201 148 147 131 45 763 656 742 58.6 80.2 53.8 16.5 125 244 53 141 273.5 925 5.5 12.5 264 269 166 54 33.5 77.5 548 592 878 28.1 58.9 81.1